Effects of empagliflozin in patients with heart failure and preserved ejection fraction according to baseline diuretic use: results from the EMPEROR-Preserved trial

Authors
Category Primary study
Conference43rd European Society of Cardiology Congress, ESC 2022
Year 2022
This article has no abstract
Epistemonikos ID: 301c6d42883f8506cc7bb7fa923858e38954a43e
First added on: Nov 03, 2023